- Home
- PED vs RVPH Comparison
PED vs RVPH Comparison
Compare PED & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PED
- RVPH
- Stock Information
- Founded
- PED N/A
- RVPH 2006
- Country
- PED United States
- RVPH United States
- Employees
- PED N/A
- RVPH N/A
- Industry
- PED Oil & Gas Production
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- PED Energy
- RVPH Health Care
- Exchange
- PED Nasdaq
- RVPH Nasdaq
- Market Cap
- PED 77.0M
- RVPH 87.6M
- IPO Year
- PED N/A
- RVPH N/A
- Fundamental
- Price
- PED $0.90
- RVPH $1.77
- Analyst Decision
- PED Strong Buy
- RVPH Strong Buy
- Analyst Count
- PED 3
- RVPH 5
- Target Price
- PED $1.83
- RVPH $12.00
- AVG Volume (30 Days)
- PED 98.5K
- RVPH 3.3M
- Earning Date
- PED 03-17-2025
- RVPH 11-14-2024
- Dividend Yield
- PED N/A
- RVPH N/A
- EPS Growth
- PED 125.69
- RVPH N/A
- EPS
- PED 0.02
- RVPH N/A
- Revenue
- PED $35,719,000.00
- RVPH N/A
- Revenue This Year
- PED $26.32
- RVPH N/A
- Revenue Next Year
- PED $2.77
- RVPH N/A
- P/E Ratio
- PED $36.89
- RVPH N/A
- Revenue Growth
- PED 19.19
- RVPH N/A
- 52 Week Low
- PED $0.61
- RVPH $0.60
- 52 Week High
- PED $1.10
- RVPH $4.83
- Technical
- Relative Strength Index (RSI)
- PED 64.37
- RVPH 49.95
- Support Level
- PED $0.80
- RVPH $1.56
- Resistance Level
- PED $0.89
- RVPH $1.86
- Average True Range (ATR)
- PED 0.03
- RVPH 0.25
- MACD
- PED 0.01
- RVPH -0.03
- Stochastic Oscillator
- PED 95.98
- RVPH 34.43
About PED Pedevco Corp.
PEDEVCO Corp is an oil and gas company focused on the acquisition and development of oil and natural gas assets in modern drilling and completion techniques and technologies have yet to be applied. The company focuses on legacy proved properties where there is a long production history, well-defined geology and existing infrastructure that can be leveraged when applying modern field management technologies. The current properties of the company are located in the San Andres formation of the Permian Basin situated in West Texas and eastern New Mexico (the Permian Basin) and in the Denver-Julesberg Basin (D-J Basin) in Colorado and Wyoming.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.